Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s diseaseMatthew R. Brier, Beau M. Ances, Anne M. Fagan et al.|Science Translational Medicine|2016Cited by 747
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case reportJoseph F. Arboleda‐Velásquez, Yakeel T. Quiroz, Francisco Lopera et al.|Nature Medicine|2019Cited by 606
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological studyEric M. Reiman, Clinton T. Baldwin, Joseph F. Arboleda‐Velásquez et al.|Nature Communications|2020Cited by 493
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s diseaseTammie L.S. Benzinger, John C. Morris, Tyler Blazey et al.|Proceedings of the National Academy of Sciences|2013Cited by 388
Partial volume correction in quantitative amyloid imagingYi Su, Tammie L.S. Benzinger, Tyler Blazey et al.|NeuroImage|2014Cited by 253